New Zealand Parliament.
1 February, 2011
The Government welcomes the Report of the Māori Affairs Committee on its Inquiry into the tobacco industry in Aotearoa and the consequences of tobacco use for Māori.
Jackson, G., Thornley, S., Woolston, J., Papa, D., Bernacchi, A., & Moore, T.
30 January, 2011
This study investigated the impact of the Healthy Housing Programme in reducing acute hospitalisations in South Auckland, New Zealand.
12 December, 2010
In a randomized cross-over trial, cromoglycate, formoterol and montelukast were equally effective in low FENO patients.
NZ House of Representatives Māori Affairs Committee.
11 November, 2010
With smoking rates amongst Māori double that of the general population, tobacco has a particularly devastating impact on Māori, and accounts for a significant portion of the life expectancy differential between Māori and non-Māori.
Gander, P., Scott, G., Mihaere, K., & Scott, H.
27 August, 2010
Aim: To estimate the societal costs of obstructive sleep apnoea syndrome (OSAS) in New Zealand and develop a simulation tool to evaluate treatment options.
Ministry of Health.
2 February, 2010
The report describes the health literacy skills of Māori compared to non-Māori. Data in the report are sourced from the 2006 Adult Literacy and Lifeskills Survey (ALL) that New Zealand participates in along with other OECD countries.
Gupta, S., Siddiqui, S., Haldar, P., Vimal Raj, J., Entwisle, J., Wardlaw, A., et al.
1 December, 2009
High-resolution CT (HRCT) scanning is part of the management of severe asthma, but its application varies between centers.
Mihaere, K., Harris, R., Gander, P., Reid, P., Purdie, G., Robson, B., et al.
31 July, 2009
Study Objectives: Examine the distribution of symptoms and risk factors, and estimate the prevalence of obstructive sleep apnea (OSA) among Māori and non-Māori New Zealanders.
Haidopoulou, K., Calder, A., Jones, A., Jaffe, A., & Sonnappa, S.
9 June, 2009
Primary immunodeficiency is a common cause of bronchiectasis in children. The term bronchiectasis suggests an irreversible process; however, disease progression following treatment is controversial. The aim of this study was to evaluate the progression of bronchiectasis in children with primary immunodeficiency after institution of treatment. The authors concluded that bronchiectasis secondary to primary immunodeficiency in childhood is not always a progressive condition, suggesting a potential to slow or prevent disease progression with appropriate treatment.
Chapman, R., Howden Chapman, P., Viggers, H., O’Dea, D., & Kennedy, M.
4 April, 2009
Housing is an important environmental influence on population health, and there is growing evidence of health effects from indoor environment characteristics such as low indoor temperatures.